Notifications
Clear all
Topic starter
14/08/2026 6:34 pm
TL;DR: Healthcare teams that handle PHI cannot treat SOC 2 as the end state because HIPAA becomes a legal obligation the moment PHI is created, received, maintained, or transmitted, and HHS has proposed stricter Security Rule requirements for 2026, according to Drata. The sequencing problem is real: HIPAA first, then the right HITRUST tier, because control maturity matters more than buying extra assurance too early.
NHIMG editorial — based on content published by Drata: Healthcare post-SOC 2 compliance now starts with HIPAA
By the numbers:
- HITRUST e1 covers roughly 44 controls and runs $35,000 to $50,000.
- HITRUST i1 covers around 182 controls and runs $70,000 to $120,000.
- HITRUST r2 scores 200-plus controls against maturity and can run $100,000 to $500,000 or more.
Questions worth separating out
Q: How should healthcare teams sequence SOC 2, HIPAA, and HITRUST after certification?
A: Start with PHI flow mapping, then make HIPAA operational, then choose HITRUST only when a buyer contract or market requirement justifies it.
Q: Why do HIPAA requirements usually come before HITRUST for healthcare vendors?
A: Because HIPAA is a legal obligation the moment PHI is created, received, maintained, or transmitted.
Q: What do healthcare teams get wrong about post-SOC 2 compliance planning?
A: They often treat SOC 2 as if it were the final assurance state and then add HITRUST without first validating whether the organisation is actually handling PHI correctly.
Practitioner guidance
- Map PHI flows before selecting the next framework Inventory every place PHI enters, moves through, or leaves the environment, including subprocessors and any workflow touching a covered entity's data.
- Operationalise HIPAA before buying more assurance Close the Security Rule gaps that SOC 2 does not fully cover, especially PHI-specific administrative controls, breach procedures, and access evidence.
- Confirm the required HITRUST tier in contract language Read the buyer requirement carefully and verify whether it calls for e1, i1, or r2 before scoping the assessment.
What's in the full article
Drata's full post covers the operational detail this analysis intentionally leaves for the source:
- A step-by-step breakdown of how to map existing SOC 2 evidence to HIPAA Security Rule safeguards.
- A cost and scope comparison of HITRUST e1, i1, and r2 for different healthcare sales motions.
- A practical sequencing model for deciding when HIPAA comes first and when HITRUST becomes necessary.
- The specific control and documentation gaps healthcare teams should expect to close before an external assessment.
👉 Read Drata's healthcare sequencing analysis for SOC 2, HIPAA, and HITRUST →
HIPAA vs HITRUST after SOC 2: what healthcare teams need now?
Explore further
14/08/2026 6:41 pm
HIPAA is the real post-SOC 2 baseline in healthcare. SOC 2 may satisfy buyer diligence, but it does not decide whether PHI handling is legally defensible. Once PHI enters the environment, the organisation needs controls mapped to HIPAA's Privacy, Security, and Breach Notification Rules, which means assurance must be tied to regulated data flows rather than generic trust language. The practitioner conclusion is simple: treat HIPAA operationalisation as the next control milestone, not as paperwork.
A question worth separating out:
Q: Who is accountable if a healthcare organisation chooses the wrong HITRUST tier?
A: Accountability sits with the team that approved scope, usually across security, compliance, and procurement. The wrong tier is not just a certification mistake. It can create budget overruns, timeline slippage, and a mismatch between what the buyer asked for and what the organisation prepared to prove.
👉 Read our full editorial: Healthcare post-SOC 2 compliance now starts with HIPAA
